In particular, in response to different signals released by the tumour microenvironment, such as TGFβ, they shift toward a pro-tumour phenotype (N2 TANs), whereas interferon (IFN)β stimulates the neutrophil anti-tumour phenotype (N1) [7]. The gene discussed is TGFB1; the disease is neoplasm.